Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JNJ-39588146 in Subjects With Heart Failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs RT 400 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 24 Mar 2012 This trial is recruiting in Belgium.
- 24 Mar 2012 Additional location (Italy) added as reported by European Clinical Trials Database.
- 23 Nov 2011 Actual patient number is 62 according to ClinicalTrials.gov.